Good practices for Pharmaceutical Microbiology Laboratories

The WHO document has a relatively narrow scope in terms of the perceived activities of a pharmaceutical microbiology laboratory and the scope is certainly inwards, in terms of the way a laboratory is run, rather than focusing outwards on the activities which laboratory staff might undertake. For example, the document is concerned with viable microbiological environmental monitoring within the laboratory but not with the activities of microbiology staff going into process areas to take airborne particle counts and to collect viable monitoring samples. This seems a little limited since the case for monitoring in an unclassified laboratory is somewhat debatable and the latter is something which occupies the time of many laboratory staff.